Our findings suggest that targeting the pathways influenced by miR-4488 or MMP2 in tumor-associated macrophages could disrupt the metabolic and immune suppression interplay between tumors and macrophages, presenting a promising therapeutic approach to combat liver metastasis. The gene discussed is MMP2; the disease is neoplasm.